Gritstone bio, Inc.   NASDAQ (GRTS)

11.12    $0.28   2.58%
At close   Friday, Nov 26 04:00 PM

Gritstone bio, Inc. Chart

GRTS Stock Price Today

Gritstone bio, Inc. (GRTS) stock rallied over 2.58% intraday to trade at $11.12 a share on NASDAQ. The stock opened with a gain of 1.66% at $11.02 and touched an intraday high of $11.50, rising 6.09% against the last close of $10.84. The stock went to a low of $10.62 during the session.

Stock Snapshot

10.84
Prev. Close
11.02
Open
754.60M
Market Cap
77.78M
Number of Shares
10.62
day Low
11.50
Day High
11.12
-
P/E ratio
3.15%
Free Float in %
-1.07
EPS (TTM)
2.67
Book Value per Share
2.94
Cash Flow per Share
561719
Volume

Gritstone bio, Inc. Historical Data

DateOpenCloseDaily HighDaily LowVolume
2021-11-24$10.12$10.84$10.90$10.00483,300
2021-11-23$10.33$10.18$10.50$9.571,131,200
2021-11-22$11.17$10.46$11.34$10.411,012,000
2021-11-19$11.10$11.18$11.48$11.00814,600
2021-11-18$10.97$11.16$11.23$10.80824,000
2021-11-17$10.81$10.89$11.07$10.65687,400
2021-11-16$11.06$10.87$11.12$10.661,319,100
2021-11-15$11.29$11.24$11.30$10.86729,000
2021-11-12$11.50$11.28$11.50$10.91550,700
2021-11-11$11.45$11.24$12.00$11.02718,700
2021-11-10$11.06$11.27$12.09$10.891,158,500

Contact Details

5959 Horton Street
Suite 300
EmeryVille, CA 94608
United States
http://gritstonebio.com
510 871 6100

About Company

Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing tumor-specific cancer immunotherapies to fight various cancer types and infectious diseases. Its lead product candidate is GRANITE, which is in Phase I/II clinical trial for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder and microsatellite stable, and colorectal cancers. The company is also developing SLATE, an off-the-shelf immunotherapy candidate for the treatment of common solid tumors, including metastatic non-small cell lung cancer, colorectal cancer, pancreatic cancer, and other mutation-positive tumors. Gritstone Oncology, Inc. has a strategic collaboration with bluebird bio, Inc. The company was formerly known as Gritstone Oncology, Inc. and changed its name to Gritstone bio, Inc. in May 2021. Gritstone bio, Inc. was founded in 2015 and is headquartered in Emeryville, California.

Frequently Asked Questions

What is the current Gritstone bio, Inc. (GRTS) stock price?

Gritstone bio, Inc. (NASDAQ: GRTS) stock price is $11.12 as of the last check on Friday, Nov 26. During the trading session, GRTS stock reached the peak price of $11.50 while $10.62 was the lowest point it dropped to.

GRTS's industry and sector of operation?

The NASDAQ listed GRTS is part of Biotechnology industry that operates in the broader Healthcare sector. Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing tumor-specific cancer immunotherapies to fight various cancer types and infectious diseases.

Who are the executives of GRTS?

Dr. Andrew R. Allen
Co-Founder, Pres, CEO, Interim Principal Financial Officer & Director

Dr. Karin Jooss
Exec. VP of Research & Chief Scientific Officer

Prof. Raphael F. Rousseau M.D., Ph.D.
Exec. VP & Chief Medical Officer

Mr. James Cho
VP of Fin. & Principal Accounting Officer


What is the GRTS stock price today?

GRTS stock traded closed the last session at $11.12, which is $0.28 or 2.58% higher than its previous close of $10.84. GRTS's current trading price is -68.41% lower than its 52-week high of $35.20 where as its distance from 52-week low of $2.86 is 288.81%.

How many employees does GRTS have?

Number of GRTS employees currently stands at 169. GRTS operates from 5959 Horton Street Suite 300 EmeryVille, CA 94608 United States.

Link for GRTS official website?


How do I contact GRTS?

GRTS could be contacted at 5959 Horton Street Suite 300 EmeryVille, CA 94608 United States, or at phone # 510 871 6100 and can also be accessed through its website: http://gritstonebio.com

How many shares of GRTS are traded daily?

GRTS stock volume for the day was 561719 shares while in the previous session number of GRTS shares traded was 483300. The average number of GRTS shares traded daily for last 3 months was 1.02M.

How much did GRTS change today?

The percentage change in GRTS stock occurred in the recent session was 2.58% while the dollar amount for the price change in GRTS stock was $0.28.

What price range GRTS stock been trading in?

In the recent session, the day high for GRTS stock was $11.50 while the low for GRTS stock touched on the day was $10.62.

What is the market cap of GRTS currently?

The market value of GRTS currently stands at $754.60M with its latest stock price at $11.12 and 77.78M of its shares outstanding.

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam